GSK turns to insider to be next CEO — and the stock rallies

Core Viewpoint - Shares of U.K. pharmaceutical giant GSK experienced a rally following the announcement of an insider being appointed as the next CEO [1] Company Summary - GSK is a major player in the pharmaceutical industry, and the recent leadership change is seen as a strategic move to stabilize and enhance company performance [1]